SCHEMBL14587261

SCHEMBL14587261

CC(C(=O)O)(c1ccccc1)C1CCC1

nearest known ligand 0.56

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.56
NFE2L2 Q16236 1/20 0.56
CHRM3 P20309 14/20 0.54
CHRM2 P08172 6/20 0.50
CHRM4 P08173 6/20 0.50
CHRM1 P11229 6/20 0.50
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAPT P10636 1/20 0.41
KMT2A Q03164 1/20 0.41
LMNA P02545 1/20 0.41
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4203042 0.96 KEAP1 (0.61) KEAP1NFE2L2CHRM3CHRM2CHRM4
SCHEMBL4213705 0.96 KEAP1 (0.61) KEAP1NFE2L2CHRM3CHRM2CHRM4
SCHEMBL4203592 0.96 KEAP1 (0.61) KEAP1NFE2L2CHRM3CHRM2CHRM4
SCHEMBL2788610 0.95 KEAP1 (0.59) KEAP1NFE2L2CHRM3CHRM2CHRM4
SCHEMBL4243228 0.92 KEAP1 (0.50) KEAP1NFE2L2CHRM3CHRM2CHRM4
SCHEMBL27749385 0.92 KEAP1 (0.50) KEAP1NFE2L2CHRM3CHRM2CHRM4
SCHEMBL4243455 0.92 KEAP1 (0.50) KEAP1NFE2L2CHRM3CHRM2CHRM4
SCHEMBL9856165 0.87 KEAP1 (0.47) KEAP1NFE2L2CHRM3CHRM2CHRM4
SCHEMBL13928640 0.85 CHRM3 (0.57) KEAP1NFE2L2CHRM3CHRM2CHRM4
SCHEMBL4245314 0.84 CHRM3 (0.60) KEAP1NFE2L2CHRM3CHRM2CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101490003-A New alkyl esters of cyclic amino alcohols with muscarinic m3 receptor antagonist activity, useful for treating e.g. chronic bronchial obstruction, asthma and overactive bladder ASTRAZENECA AB (SE) 2009-07-22 CN disclosed
US-7179802-B2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia MERCK & CO., INC. (US) 2007-02-20 US disclosed
US-7179802-B2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia MERCK & CO., INC. (US) 2007-02-20 US disclosed